Anaysts recommend a 'buy' on Icra due to its positive outlook.
Anaysts recommend a 'buy' on Icra due to its positive outlook.
IT and pharma companies again save the day; mask pain in domestic consumption.
In Q3, E&P business accounted for just 1.5% of gross revenue
While TCS will see demand in the US and Europe, its local business is likely to be hit on poor IT spending.
Another year of strong performance by these export-oriented sectors likely as US economy revives and rupee is expected to be under pressure.
Given their growth prospects and reasonable valuations, Mindtree, Hexaware and NIIT remain top picks of most analysts.
Analysts are divided on the deal valuations. Some say Torrent could have bargained harder, as Sanofi, among others, passed it over.
The sharp fall in the rupee's value against the dollar during the July-September quarter, it turns out, has come as a boon for corporate earnings.
Even as the September quarter performance was subdued, analysts expect the second half to be better on higher prices, output.
Good performances by most information technology (IT) companies in the September quarter and improved forecasts notwithstanding, with the exception of Infosys, stocks of IT biggies such as TCS, Wipro and HCL Technologies have fallen three to nine per cent since Infosys announced its earnings on October 11.
After steep correction in valuations, these have turned attractive but upside will depend on diesel price rises and export-parity pricing.
Banking stocks, including top ones like State Bank of India, ICICI Bank, HDFC Bank, Bank of Baroda and Bank of India, among others, have fallen sharply in the last one month.
Analysts are eyeing bigger launches that will positively impact company's fortunes.
.jpg)
While cost pressures could partly offset the expected gains, given the currency hedging by companies the gains will not accrue immediately.
Analysts see a buy opportunity as gap with peers is now at 37% compared to 13% historically.
Concerns on lower natural gas transmission, LPG rate cut & APM gas price hike might be priced in but no positive triggers
Given the strong prospects in the business, analysts expect the company to clock healthy growth of 15-20 per cent, going ahead.
Good growth prospects and reasonable valuations will help select mid-caps deliver superior returns, say experts.
Analysts believe there could be some pressure on banks' margins in the interim.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances